Perjeta, which is pertuzumab, is a important advancement in managing HER2-positive mammary cancer. This drug works by targeting a particular pathway on helps cancer cells multiply . Differing from some other HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 receptor itself, but ins